Abstract: Background Gastrin-releasing peptide (GRP), a neuropeptide, belongs to the bombesin (BB) and is expressed in various organs (such as gastrointestinal system, respiratory system, nervous system, endocrine gland and skeletal muscles). Gastrin-releasing peptide receptors (GRPR) is a kind of G protein coupled receptors (GPCRs). In recent years, more and more studies have focused on potential roles of GRP in inflammatory diseases. RC-3095, as a specific GRPR antagonist, has been found to have anti-inflammatory properties. Objective To investigate the potential roles and research situation of GRP-GRPR in inflammatory diseases. Content Mainly focusing on reviewing sepsis, arthritis, gastroenteritis, and uveitis, we summarized the roles of GRP-GRPR in inflammatory diseases. Trend In conclusion, GRP and its receptor is a potential therapeutic target in inflammatory diseases as well as the possible transformation from preclinical findings to clinical application.
|